Related Experiment Videos
Progress in evaluation of the potential of antisense technology
Antisense Research and Development
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The concept and application of antisense oligonucleotides.
Diseases of the colon and rectum·2001
Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration.
Biochemical pharmacology·2001
Investigating the structure of human RNase H1 by site-directed mutagenesis.
The Journal of biological chemistry·2001
Variations in mRNA content have no effect on the potency of antisense oligonucleotides.
Antisense & nucleic acid drug development·2001
Human RNase III is a 160-kDa protein involved in preribosomal RNA processing.
The Journal of biological chemistry·2000
Bovine serum albumin is a major oligonucleotide-binding protein found on the surface of cultured cells.
Antisense research and development·1995
Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
Antisense research and development·1995
Digoxigenin-labeled phosphorothioate oligonucleotides: a new tool for the study of cellular uptake.
Antisense research and development·1995
Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.
Antisense research and development·1995
The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries.
Antisense research and development·1995
Trojan mast cells: repurposing allergy for targeted oncolytic delivery.
Trends in pharmacological sciences·2026
Remote photobiomodulation: A systemic approach to neuroprotection.
International review of neurobiology·2026
Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026